Table 1.
Variable | HPCC (N=124) | Overall 1917 clinic (N=1368) |
---|---|---|
Age (median, IQR)* | 44 (38–49) | 42 (34–49) |
Nonwhite race | 56 (46%) | 754 (56%) |
Female | 37 (30%) | 309 (23%) |
Transmission risk Factor* | ||
Heterosexual | 45 (36%) | 472 (35%) |
Intravenous drug use | 29 (23%) | 102 (7%) |
Men who have sex with men | 49 (40%) | 737 (54%) |
Other/unknown | 1 (1%) | 57 (4%) |
Insurance* | ||
Private | 17 (14%) | 538 (39%) |
Public | 72 (58%) | 346 (25%) |
None | 35 (28%) | 484 (35%) |
CD4 (median, IQR) | 352 (209–639) | 407 (231–608) |
VL undetectable | 69 (56%) | 652 (48%) |
Pain | 96 (78%) | 427 (32%) |
Depression (PHQ-9 ≥10)* | 43 (35%) | 208 (15%) |
Anxiety* | 40 (33%) | 247 (18%) |
Substance abuse* | ||
current | 8 (7%) | 116 (9%) |
prior | 68 (56%) | 375 (28%) |
never | 46 (38%) | 864 (64%) |
Psychiatry/psychology visit* | 94 (76%) | 506 (37%) |
Impaired mobility* | 58 (47%) | 199 (15%) |
Impaired self-care* | 14 (11%) | 48 (4%) |
Impaired usual activities* | 63 (51%) | 214 (16%) |
Comorbidities | ||
COPD* | 11 (8.9%) | 39 (2.9%) |
Sleep disorders* | 59 (48%) | 427 (31%) |
Cardiovascular* | 14 (11%) | 89 (7%) |
Depression* | 84 (68%) | 645 (47%) |
Anxiety* | 42 (34%) | 323 (27%) |
Bipolar* | 13 (11%) | 42 (3%) |
p<0.05.
COPD, chronic obstructive pulmonary disease; HPCC, HIV palliative care clinic; IQR, interquartile range; PHQ-9A, anxiety symptoms, panic; VL, viral load.